1YIN H, HAVRILLA C M, GAO L, et al. Mechanisms for the formation of isoprostane endoperoxides from arachidonic acid[J]. Biol Chem, 2003, 278 (19): 720-725. 被引量：1
2ROBERTS II L J, MONTINE T J, MARKESBERY W R, et al. Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid [ J ]. Biol Chem,1998, 273 (22): 605-612. 被引量：1
3PRATICO D, LAWSON J A, ROKACH J, et al. The isoprostanes in biology and medicine [ J ] . Trends Endocrinol Metab ,2001,12(6) :243-247. 被引量：1
4BASSENGE E, SCHNEIDER H T, DAIBER A. Oxidative stress and cardiovascular diseases [ J ]. Dtsch Med Wochenschr, 2005, 130(50): 2904-2909. 被引量：1
6FUJITA K, NISHIZAWA H, FUNAHASHI T, et al. Systemic oxidative stress associated with visceral fat accumulation and the metabolic syndrome [ J ]. Circ, 2006, 70(11) : 1437-1442. 被引量：1
7MORROW J D. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans[J]. Arterioscler Thromb Vase Biol, 2005, 25(2) :279-286. 被引量：1
8MUELLER T, DIEPLINGER B, GEGENHUBER A, et al. Serum total 8-isoprostaglandin F2alpha: a new and independent predictor of peripheral arterial disease [ J]. Vasc Surg, 2004, 40: 768-773. 被引量：1
9ORINA B, DARA B, DERMOT K, et al. Cyclooxygenase-1 and 2-dependent prosttacyclin formation in patients with atherosclerosis[J]. Circ, 2002, 102(8): 840-845. 被引量：1
10BIN W, JINSHUN P, LIANSHENG W,et al. Associations of plasma 8-isoprostane levels with the presence and extent of coronary stenosis in patients with coronary artery disease [J]. Atheroscler, 2006, 184 (2): 425-430. 被引量：1
